At every stage in your #hepatology career, you deserve a chance to: ✅ Attend The Liver Meeting® and other world-class meetings ✅ Nominate for leadership opportunities ✅ Advance your career using AASLD's Career Center Renew your AASLD membership today and maintain access to your unbeatable benefits. https://bit.ly/4sMOw3e
American Association for the Study of Liver Diseases (AASLD)
Non-profit Organizations
Alexandria, Virginia 17,120 followers
Our mission: To advance and disseminate the science and practice of hepatology, and to promote liver health and quality
About us
The American Association for the Study of Liver Diseases (AASLD) is the nation’s premier organization of physicians, scientists, researchers, medical students, and healthcare professionals to study, prevent, and cure liver diseases. AASLD was founded in 1950 by a group of leading liver specialists to advance the field of hepatology. The mission of AASLD is to advance and disseminate the science and practice of hepatology and to promote improved liver health and quality patient care. AASLD has more than 7,000 + members who work in hepatology and related areas. AASLD advances the study and treatment of liver diseases in these diverse ways: · The Liver Meeting, AASLD’s annual meeting that features interactive sessions on the latest breakthroughs, advancements, and research in liver health, education workshops, and exhibits featuring state-of-the-art technologies, pharmaceutical developments, and medical devices. · Practice guidelines developed by a multidisciplinary panel of experts to share recommended approaches to the diagnosis, therapeutic, and preventive aspects of care along with quality measures to help its members measure healthcare processes and outcomes. · Journals that feature the latest research, review, practice guidelines and more on liver disease. These include Hepatology, the premier publication in the field of liver disease; Clinical Liver Disease, a free access multimedia review journal; and Hepatology Communications, a peer-reviewed, online, and open access journal. · Clinical resources for hepatologists and other clinicians. · Courses for clinicians and other healthcare professionals. · Tools to help professionals communicate effectively with patients. · The Cirrhosis Quality Collaborative, a multi-site learning health network that combines quality improvement and research to improve the care and treatment of patients with cirrhosis.
- Website
-
http://www.aasld.org
External link for American Association for the Study of Liver Diseases (AASLD)
- Industry
- Non-profit Organizations
- Company size
- 11-50 employees
- Headquarters
- Alexandria, Virginia
- Type
- Nonprofit
- Founded
- 1950
- Specialties
- hepatology, liver disease, CME, and education
Locations
-
Primary
Get directions
1001 N Fairfax Street
4th floor
Alexandria, Virginia 22314, US
-
Get directions
Employees at American Association for the Study of Liver Diseases (AASLD)
Updates
-
🚨 We need your help! The administration has released its #FY27Budget Request, proposing significant cuts to the National Institutes of Health #NIH and Centers for Disease Control and Prevention #CDC, along with a reorganization of NIH institutes and CDC programs. These changes could have serious consequences for #liverdisease research and #hepatitis prevention. 👉 Take action now using the #AASLD Policy Action Center: https://bit.ly/3YVavso
-
-
Power up your academic hepatology career by applying for the 2026 AASLD - EASL Masterclass in Alexandria, VA! Junior faculty, applications for the unique two-day program are now open. Apply today: https://bit.ly/3Oe7pOx EASL | The Home of Hepatology
-
-
Don’t miss tomorrow’s panel discussion on the medical, ethical, and social challenges in determining eligibility, managing post-transplant care, and addressing the stigma surrounding alcohol use disorder (AUD) in liver transplantation. Register now: https://bit.ly/4mnsUsI
-
-
🧡Happy #VolunteerAppreciationWeek! To our incredible #AASLD members, your time, expertise, and passion power our mission and strengthen the #hepatology community every day. Thank you!
-
-
#Liverdisease is a major and growing global public health burden, affecting an estimated 1.5 billion people worldwide. Unfortunately, many of these conditions develop silently, progressing for years without symptoms until significant damage has occurred. The good news? Many forms of liver disease are preventable, and even when not fully preventable, they are often manageable if caught early. View the AASLD #WorldLiverDay blog “Why Liver Health Checkups Matter: Detecting Disease Before Symptoms Appear.” World Liver Day 🔗 https://bit.ly/4ckvlZQ
-
-
The 2026 #WorldLiverDay campaign “Solid Habits, Strong Liver” highlights the importance of everyday behaviors including balanced nutrition, reducing alcohol-related harm, physical activity, and regular checkups, in protecting liver health. View this AASLD blog on “Alcohol and #LiverHealth: Why Reducing Intake Matters.” World Liver Day 🔗 https://bit.ly/4m1Ftd0
-
-
Today is #WorldLiverDay! AASLD is proud to stand alongside our sister societies — ALEH - Asociación Latinoamericana para el Estudio del Hígado, APASL 2026 Istanbul, EASL | The Home of Hepatology, and SOLDA - Society on Liver Disease in Africa — in a united effort to advance liver health worldwide through prevention, early detection, and patient care. 🎥 View this message from AASLD President Saul J. Karpen, MD, PhD, FAASLD. World Liver Day https://lnkd.in/e4uGinBa
World Liver Day 2026 Greeting - Saul J. Karpen, AASLD President, MD, PhD, FAASLD
https://www.youtube.com/
-
This #NationalDonateLifeMonth, AASLD is elevating the voices of #livertransplant recipients by highlighting the profound impact of organ donation. Read reflections from patient advocate and #livertransplant recipient Beth Lehman and pediatric transplant recipient Kareena. Both offer important insight for the #hepatology community. Explore their stories here: https://bit.ly/4citwwn
-
-
Co-Editors-in-Chief Elliot Tapper, MD, FAASLD, and Carmen Chak-Lui Wong, PhD, share highlights from the April issue of #HepatologyCommunications including a consensus statement on portal hypertension, advances in #HCC screening and treatment, insights into #MASH #cirrhosis, and emerging immune targets in #liverdisease. Watch below and view the latest issue here: https://bit.ly/4sf5gBm https://lnkd.in/e-74DH9T
Hepatology Communications Highlights: April 2026
https://www.youtube.com/